MusclePharm Announces Third Quarter 2020 Financial Results
December 01, 2020
CALABASAS, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- MusclePharm Corp Inc. (OTCQB: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported financial results for the quarter and nine months ended September 30, 2020.
The following are key financial highlights for the period. Reconciliations of certain GAAP to non-GAAP measures are provided later in this press release.
Third Quarter 2020 Compared to Third Quarter 2019
Revenue, net was $16.1 million compared to $21.2 million.
Gross margin improved to 31.2% compared to 7.2%.
Net income was $678,000 compared to a net loss of $(5.1) million.
Diluted income per share was $0.01 compared to diluted loss per share of $(0.27).
Adjusted EBITDA was $1.0 million compared to negative Adjusted EBITDA of $(4.1) million. http://ir.musclepharmcorp.com/prviewer/release_only/id/4548989